Skip to main content
Log in

Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients

Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Protein carbonyl levels, a measure of protein oxidation, were found to be significantly elevated (p < 0.0005) in the sera of chronic fatigue syndrome (CFS) patients vs. controls. In contrast, the total protein levels in sera CFS patients were unchanged from those of controls. The elevated protein carbonyl levels confirm earlier reports suggesting that oxidative stress is associated with chronic fatigue syndrome and are consistent with a prediction of the elevated nitric oxide/peroxynitrite theory of chronic fatigue syndrome and related conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fukuda K, Stauss SE, Hickie I, Sharpe MC, Dobbin JG, Komaroff A: The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Group. Ann Intern Med 121: 953-959, 1994

    Google Scholar 

  2. Whiteside TL, Friberg D: Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 105: 27S-34S, 1998

    Google Scholar 

  3. Patarca R: Cytokines and chronic fatigue syndrome. Ann NY Acad Sci 933: 185-200, 2001

    Google Scholar 

  4. Komaroff AL, Buchwald DS: Chronic fatigue syndrome: An update. Ann Rev Med 49: 1-13, 1998

    Google Scholar 

  5. Patarca-Montero R, Mark T, Fletcher MA, Klimas NG: Immunology of chronic fatigue syndrome. J Chronic Fatigue Syndr 6: 69-108, 2000

    Google Scholar 

  6. Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT: Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr 135: 494-499, 1999

    Google Scholar 

  7. Stewart JM: Orthostatic intolerance: A review with application to the chronic fatigue syndrome. J Chronic Fatigue Syndr 8: 45-64, 2001

    Google Scholar 

  8. Shetzline SE, Martinand-Marie C, Reichenbach NL, Buletic Z, Lebleu B, Pfleiderer W, Charubala R, De Meirlier K, De Becker P, Peterson DL, Herst CV, Englebienne P, Suhadolnik RJ: Structural and functional features of the 37-kDa 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 22: 443-456, 2002

    Google Scholar 

  9. Pall ML: Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypoth 54: 115-125, 2000

    Google Scholar 

  10. Pall ML: Elevated peroxynitrite as the cause of chronic fatigue syndrome: Other inducers and mechanisms of symptom generation. J Chronic Fatigue Syndr 7: 45-58, 2000

    Google Scholar 

  11. Pall ML: Cobalamin used in chronic fatigue syndrome therapy is a nitric oxide scavenger. J Chronic Fatigue Syndr 8: 39-44, 2000

    Google Scholar 

  12. Fulle S, Mecocci P, Fano G, Vecchiet I, Vecchini A, Racciotti D, Cherubini A, Pizzigallo E, Vecchiet L, Senin U, Beal MF: Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radic Biol Med 15: 1252-1259, 2000

    Google Scholar 

  13. Richards RS, Roberts TK, Mathers MB, Dunstan RH, McGregor NR, Butt HL: Investigation of erythrocyte oxidative damage in rheumatoid arthritis and chronic fatigue syndrome. J Chronic Fatigue Syndr 6: 37-46, 2000

    Google Scholar 

  14. Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt HL: Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep 5: 35-41, 2000

    Google Scholar 

  15. Keenoy BM, Moorkens G, Vertommen J, DeLeeuw I: Antioxidant status and lipoprotein oxidation in chronic fatigue syndrome. Life Sci 68: 2037-2049, 2001

    Google Scholar 

  16. Logan AC, Wong C: Chronic fatigue syndrome: Oxidative stress and dietary modifications. Altern Med Rev 6: 450-459, 2001

    Google Scholar 

  17. Rigden S, Barrager E, Bland JS: Evaluation of the effect of a modified entero-hepatic resuscitation program in chronic fatigue syndrome patients. J Adv Med 11: 247-262, 1998

    Google Scholar 

  18. Stadtman ER, Levine RL: Protein oxidation. Ann NY Acad Sci 899: 191-208, 2000

    Google Scholar 

  19. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER: Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 186: 464-478, 1990

    Google Scholar 

  20. Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32: 797-803, 2002

    Google Scholar 

  21. Levine RL. Carbonyl modified proteins in cellular regulation, aging and disease. Free Radic Biol Med 32: 790-796, 2002

    Google Scholar 

  22. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976

    Google Scholar 

  23. Ischiropoulos H, al Mehdi AB: Peroxynitrite-meditated oxidative protein modifications. FEBS Lett 364: 279-282, 1995

    Google Scholar 

  24. Pall ML: The levels of the nitric oxide synthase product, citrulline, as elevated in sera of chronic fatigue syndrome patients. J Chronic Fatigue Syndr 10: 37-41, 2002

    Google Scholar 

  25. Farquhar WB, Hunt BE, Taylor JA, Darling SE, Freeman R: Blood volume and its relation to peak O(2) consumption and physical activity in patients with chronic fatigue. Am J Physiol Heart Circ Physiol 282: H66-H71, 2002

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smirnova, I.V., Pall, M.L. Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients. Mol Cell Biochem 248, 93–95 (2003). https://doi.org/10.1023/A:1024176016962

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024176016962

Navigation